In this activity, three experts consider best practice in the management of agitation in Alzheimer’s dementia and the potential of new pharmacological approaches that target aspects of the underlying pathophysiology. The discussion is guided by pre-canvassed questions provided by healthcare professionals involved in the management of people living with dementia associated with Alzheimer’s disease. Watch the video, "Pharmacological management of agitation in Alzheimer’s dementia: Rationale and evidence for new and emerging treatment options", here: https://touchneurologyime.org/panel-pharmacological-management-of-aad/